Literature DB >> 23900360

The role of fibrates in chronic kidney disease and diabetes mellitus.

Mark R Kahn, Michael J Robbins, Michael C Kim, Valentin Fuster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23900360     DOI： 10.1038/nrcardio.2013.15-c2

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  5 in total

1.  Lipid-lowering agents in chronic kidney disease: do fibrates have a role?

Authors:  Yuli Huang; Yunzhao Hu
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

2.  Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.

Authors:  T M E Davis; R Ting; J D Best; M W Donoghoe; P L Drury; D R Sullivan; A J Jenkins; R L O'Connell; M J Whiting; P P Glasziou; R J Simes; Y A Kesäniemi; V J Gebski; R S Scott; A C Keech
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

Review 3.  Management of cardiovascular disease in patients with kidney disease.

Authors:  Mark R Kahn; Michael J Robbins; Michael C Kim; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2013-02-19       Impact factor: 32.419

4.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

5.  Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants.

Authors:  Josyf C Mychaleckyj; Timothy Craven; Uma Nayak; John Buse; John R Crouse; Marshall Elam; Kent Kirchner; Daniel Lorber; Santica Marcovina; William Sivitz; Joann Sperl-Hillen; Denise E Bonds; Henry N Ginsberg
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112
  5 in total
  1 in total

1.  Prevalence and factors associated with chronic kidney disease among medical inpatients at the Kenyatta National Hospital, Kenya, 2018: a cross-sectional study.

Authors:  Valerian Mwenda; Jane Githuku; Gladwell Gathecha; Benjamin Maranga Wambugu; Zeinab Gura Roka; Willis Owino Ong'or
Journal:  Pan Afr Med J       Date:  2019-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.